Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$3.61 +0.20 (+6.02%)
At close: Oct 2, 2026 · 4:00 PM EDT

Galmed Pharmaceuticals (EOCN) Selling, General & Administrative (2013 - 2026)

Updated

Galmed Pharmaceuticals (EOCN) posted Selling, General & Administrative of $993,000 for Q2 2026, down 5.5% from $1.05 million a year earlier but up 45.2% from the prior quarter.

Analysis

Galmed Pharmaceuticals (EOCN) Selling, General & Administrative (2013 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Galmed Pharmaceuticals was $598,000, down 19.3% year-over-year; for FY2025, it came in at $602,000, up 17.1% from FY2024.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of -32.0% (FY2020 to FY2025).
  • In prior years, Galmed Pharmaceuticals' Selling, General & Administrative was $514,000 in FY2024 (-86.9%), $3.92 million in FY2023 (-15.7%), $4.66 million in FY2022 (-17.8%) and $5.66 million in FY2021 (+37.1%).
  • Quarterly Selling, General & Administrative has run from a low of -$2.21 million in Q4 2024 to a high of $1.3 million in Q3 2021 over five years.
  • On a year-over-year basis, Selling, General & Administrative increased in three of the last six quarters, with growth averaging 9.5%.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q2 2025, with growth of 52.8%; the weakest was Q2 2024, with a decline of 35.2%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $684,000 (Q1 2026), -$2.09 million (Q4 2025) and $1.01 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Galmed Pharmaceuticals 402,581.38 402,581.38 - 993,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 993,000.00
Mar 31, 2026 684,000.00
Dec 31, 2025 -2.09 Mn
Sep 30, 2025 1.01 Mn
Jun 30, 2025 1.05 Mn
Mar 31, 2025 630,000.00
Dec 31, 2024 -2.21 Mn
Sep 30, 2024 1.27 Mn
Jun 30, 2024 688,000.00
Mar 31, 2024 766,000.00
Dec 31, 2023 1.03 Mn
Sep 30, 2023 912,000.00
Jun 30, 2023 1.06 Mn
Mar 31, 2023 919,000.00
Dec 31, 2022 1.07 Mn
Sep 30, 2022 1.14 Mn
Jun 30, 2022 1.15 Mn
Mar 31, 2022 -30,000.00
Dec 31, 2021 1.23 Mn
Sep 30, 2021 1.30 Mn
API Access

Galmed Pharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=EOCN&period=max&api_key=YOUR_API_KEY